Alzheimer's Disease Trial, Not Yet Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- People of any gender or ethnic background who are aged 60 or older and permanently live in the Tianma area of SheMountain Town, Songjiang District (suburbs), Shanghai.
- People who agree to have information collected about them, including results from brain and behaviour assessments, biological samples (such as blood), and medical imaging.
- People who agree to take part in the study, sign a consent form, and commit to following the study procedures throughout the entire process.
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People who have a serious mental illness, cancer-related severe weight loss (cachexia), severe liver or kidney problems, or other major health conditions that make it difficult to participate.
- People who have vision or hearing problems that cannot be corrected (for example, with glasses or hearing aids) and that would prevent them from completing the required assessments.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 086-021-64370045
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
The change of incidence of cognitive impairment
Can't join this trial?
Data last synced from ClinicalTrials.gov: 6 August 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.